2Dubertret L,Leynadier MF, Murrieta-Aguttes M,et al. Effect of mizolastine (M)vs placebo in acquired cold induced urticaria (ACIU) :the cold stimulation time test. Allergy, 1998,53 ( Supp143 ) :67.
3Stem M, Blondin-Ertzbischoff P, Murrieta-Aguttes M, et al. Rapid and sustained efficacy of mizolastine 10 mg once daily in seasonal allergic rhinitis. J Int Med Res, 1998,26(6) :292-303.
4Sabbah A, Daele J, Wade AG, et al. Comparison of the efficacy,safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis. MIZOCET Study Group. Ann Allergy Asthma Immunol,1999,83(4) :319-325.
5Bachert C, Brostoff J, Scadding GK, et al. Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group. Allergy, 1998,53(10) :969-975.
6Scadding GK, Tasman AJ, Murrieta-Aguttes M,et al. Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group. J Int Med Res, 1999,27(6) :273-285.
7Freche CH, Leynadier F, Bachert C, et al. Placebo controlled study of mizolastine 10mg and loratadine 10mg once daily in perennial allergic rhinitis (PAR). Allergy, 1999,54:152.
9Benavides J, Schoemaker H, Dana C, et al. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent. Arzneimittelforschung, 1995,45(5) :551-558.
10Levrier J, Duval D, Prouteau M, et al. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Arzneimittelforschung, 1995,45 (5) :559-568.
